Abstract
AbstractNucleic acid nanodevices present great potential as agents for logic-based therapeutic intervention as well as in basic biology. Often, however, the disease targets that need corrective action are localized in specific organs and thus realizing the full potential of DNA nanodevices also requires ways to target them to specific cell-typesin vivo. Here we show that by exploiting either endogenous or synthetic receptor-ligand interactions and by leveraging the biological barriers presented by the organism, we can target extraneously introduced DNA nanodevices to specific cell types inC. elegans, with sub-cellular precision. The amenability of DNA nanostructures to tissue-specific targetingin vivosignificantly expands their utility in biomedical applications and discovery biology.
Publisher
Cold Spring Harbor Laboratory
Reference92 articles.
1. Altun, Z. F. , & Hall, D. H. (2009). Alimentary system, intestine. . WormAltas. Retrieved from http://doi:10.3908/wormatlas.1.4
2. A regulatory cascade of three homeobox genes, ceh-10, ttx-3 and ceh-23, controls cell fate specification of a defined interneuron class in C. elegans;Development,2001
3. Antibodies, M. , Phage, B. Y. , & Technology, D. (1994). MAKING ANTIBODIES BY PHAGE.
4. Quantum dot-loaded monofunctionalized DNA icosahedra for single-particle tracking of endocytic pathways
5. A synthetic icosahedral DNA-based host–cargo complex for functional in vivo imaging